These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 16188664

  • 1. Iron overload and chelation.
    Hershko C, Link G, Konijn AM, Ioav Cabantchik Z.
    Hematology; 2005; 10 Suppl 1():171-3. PubMed ID: 16188664
    [Abstract] [Full Text] [Related]

  • 2. [Post-transfusional iron overload, iron loading anemia].
    Rose C.
    Rev Med Interne; 2012 Jun; 33 Suppl 1():S15-8. PubMed ID: 22475955
    [No Abstract] [Full Text] [Related]

  • 3. Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo.
    Alessandrino EP, Angelucci E, Cazzola M, Porta MG, Di Bartolomeo P, Gozzini A, Malcovati L, Pioltelli P, Sica S, Bosi A.
    Am J Hematol; 2011 Oct; 86(10):897-902. PubMed ID: 21809371
    [No Abstract] [Full Text] [Related]

  • 4. Management of transfusion-related iron overload in patients with myelodysplastic syndromes.
    Shah J, Kurtin SE, Arnold L, Lindroos-Kolqvist P, Tinsley S.
    Clin J Oncol Nurs; 2012 Jun; 16 Suppl():37-46. PubMed ID: 22641283
    [Abstract] [Full Text] [Related]

  • 5. Iron overload and stem cell transplant-and the beat goes on.
    Tefferi A.
    Am J Hematol; 2011 Oct; 86(10):825-6. PubMed ID: 21922523
    [No Abstract] [Full Text] [Related]

  • 6. Myelodysplastic syndromes: iron overload consequences and current chelating therapies.
    Greenberg PL.
    J Natl Compr Canc Netw; 2006 Jan; 4(1):91-6. PubMed ID: 16403408
    [Abstract] [Full Text] [Related]

  • 7. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
    Kontoghiorghes GJ.
    Hemoglobin; 2009 Jan; 33(5):332-8. PubMed ID: 19814679
    [Abstract] [Full Text] [Related]

  • 8. Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies.
    Voskaridou E, Christoulas D, Terpos E.
    Br J Haematol; 2011 Sep; 154(5):654-6. PubMed ID: 21615376
    [No Abstract] [Full Text] [Related]

  • 9. The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
    Harrington JM, Mysore MM, Crumbliss AL.
    Dalton Trans; 2018 May 22; 47(20):6954-6964. PubMed ID: 29721567
    [Abstract] [Full Text] [Related]

  • 10. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A, Yazman D, Economides C, Eracleous E, Kontoghiorghes GJ.
    Hemoglobin; 2009 May 22; 33(5):312-22. PubMed ID: 19814677
    [Abstract] [Full Text] [Related]

  • 11. How we manage iron overload in sickle cell patients.
    Coates TD, Wood JC.
    Br J Haematol; 2017 Jun 22; 177(5):703-716. PubMed ID: 28295188
    [Abstract] [Full Text] [Related]

  • 12. Iron chelation therapy for patients with myelodysplastic syndrome.
    Yeh SP, Yang YS, Yao CY, Peng CT.
    Hemoglobin; 2009 Jun 22; 33(5):339-45. PubMed ID: 19814680
    [Abstract] [Full Text] [Related]

  • 13. Iron chelation therapy for transfusional iron overload: a swift evolution.
    Musallam KM, Taher AT.
    Hemoglobin; 2011 Jun 22; 35(5-6):565-73. PubMed ID: 21910602
    [Abstract] [Full Text] [Related]

  • 14. Combined iron chelation therapy.
    Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW.
    Ann N Y Acad Sci; 2010 Aug 22; 1202():79-86. PubMed ID: 20712777
    [Abstract] [Full Text] [Related]

  • 15. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
    Ha SY, Mok AS, Chu WC, Raskalkar DD, Cheuk DK, Chiang AK, Ho MH, Chan GC.
    Hemoglobin; 2009 Aug 22; 33(5):323-31. PubMed ID: 19814678
    [Abstract] [Full Text] [Related]

  • 16. Iron chelation therapy in myelodysplastic syndromes: we need more evidence, not more guidelines.
    Butler A, Patton WN.
    Intern Med J; 2012 May 22; 42(5):481-4. PubMed ID: 22616959
    [No Abstract] [Full Text] [Related]

  • 17. Iron chelation: an update.
    Sheth S.
    Curr Opin Hematol; 2014 May 22; 21(3):179-85. PubMed ID: 24504090
    [Abstract] [Full Text] [Related]

  • 18. Current approach to iron chelation in children.
    Aydinok Y, Kattamis A, Viprakasit V.
    Br J Haematol; 2014 Jun 22; 165(6):745-55. PubMed ID: 24646011
    [Abstract] [Full Text] [Related]

  • 19. Management of chronic iron overload.
    Baxter B.
    Paediatr Nurs; 2002 Sep 22; 14(7):14-6. PubMed ID: 12271869
    [No Abstract] [Full Text] [Related]

  • 20. Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo.
    Taher AT, Musallam KM, Viprakasit V, Porter JB, Cappellini MD.
    Blood Cells Mol Dis; 2014 Sep 22; 52(2-3):88-90. PubMed ID: 24041597
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.